Study demonstrates pain-relieving efficacy of THC-rich cannabis flowers
“Cannabis with high THC also causes mood elevation and adjusts attentional demands, likely distracting patients from the aversive sensations that people refer to (as) pain," said UNM professor Jacob Miguel Vigil, PhD
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• September 11, 2019
Despite legalization, the CBD and hemp industries are facing discrimination
Thankfully, a chunk of legislation recently introduced – "the CLAIM Act" – could protect cannabis business owners from federal prosecution
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 21, 2019
Curaleaf removes CBD health claims from website and social media after FDA warning
Curaleaf's letter from the FDA serves as a warning for other companies in the cannabis space to hold off on developing and launching CBD-focused product lines until the FDA releases an official set of rules.
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 7, 2019
CEO of GW Pharma talks about Epidiolex getting FDA approval
The DEA must accurately categorize CBD within 90 days of the approval
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 2, 2018
Rescheduling cannabis in the States: Could the decision backfire?
Rescheduling the plant means that, although it would still be a regulated drug, cannabis would become legal for medicinal use
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• June 17, 2018
Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• May 3, 2018
FDA warns companies against claims that cannabis cures diseases
Sara Tiradossi
• November 5, 2017
Load More Stories